NCT01392014 Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases Status COMPLETED Phase PHASE4
NCT01389557 Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra Status COMPLETED Phase PHASE4
NCT01379430 Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas Status COMPLETED Phase PHASE1
NCT01378286 Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria Status COMPLETED Phase PHASE3
NCT01374581 Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria Status COMPLETED Phase PHASE3
NCT01373879 AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area Status COMPLETED Phase PHASE1
NCT01366534 Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults Status COMPLETED Phase PHASE2
NCT01364883 Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP Status COMPLETED Phase PHASE1
NCT01361269 Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria Status UNKNOWN Phase PHASE2
NCT01351948 Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909 Status COMPLETED Phase PHASE1
NCT01350752 Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of Malaria Status COMPLETED Phase NA
NCT01345240 Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) Status COMPLETED Phase PHASE3
NCT01341704 Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa Status COMPLETED Phase PHASE2
NCT01328990 Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc) Status COMPLETED Phase PHASE1/PHASE2
NCT01323972 Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children Status COMPLETED Phase PHASE3
NCT01322581 A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali Status COMPLETED Phase N/A
NCT01319448 Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2